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Background: six hours’ monitoring by transcranial Doppler (TCD) has been successful in directing Dextran therapy in
patients at high risk of thrombotic stroke after carotid endarterectomy (CEA).
Objectives: is 3 h of routine monitoring as effective as 6 h in the prevention of early postoperative thrombotic stroke?
Design: prospective, consecutive study in all patients with an accessible cranial window.
Methods: one hundred and sixty-six patients undergoing CEA underwent 3 h of postoperative monitoring by TCD. Any
patient with >25 emboli detected in any 10 min period or those with emboli that distorted the arterial waveform were
commenced on an incremental infusion of dextran 40.
Results: the majority of patients destined to embolise will do so within the first 2 postoperative hours. Dextran therapy
was instituted in nine patients (5%) and rapidly controlled this phase of embolisation although the dose had to be
increased in three (33%). No patient suffered a postoperative carotid thrombosis but one suffered a minor stroke on day
5 and was found to have profuse embolisation on TCD; high dose dextran therapy was again instituted, the embolus
count rate fell rapidly and he made a good recovery thereafter. Overall, the death and disabling stroke rate was 1.2% and
the death/any stroke rate was 2.4%.
Conclusion: three hours of postoperative TCD monitoring is as effective as 6 h in the prevention of postoperative carotid
thrombosis.
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Introduction in the majority of patients.1–3 As a consequence, we
implemented a policy of routine postoperative dextran
Thrombosis complicates up to 3% of carotid en- therapy which, while abolishing all postoperative
darterectomies (CEA) and usually manifests itself thromboses, was unfortunately associated with an in-
within the first 6 postoperative hours.1–3 In previous creased incidence of neck haematomas and one death
studies, we have shown that the introduction of a qual- due to multiorgan failure which the nephrologists
ity control programme contributed towards a sustained ascribed to the dextran therapy. In the light of this,
decline in the number of patients recovering from an- we adopted a policy of selective dextran therapy in
aesthesia with a new neurological deficit (the intra- potentially high risk patients guided by TCD evidence
operative stroke), but was not associated with a parallel of sustained postoperative embolisation.7 All CEAs
reduction in postoperative thrombotic stroke4,5 which, were subsequently monitored for 6 h, Dextran was
at re-exploration, consistently revealed friable platelet used in 5% of patients and embolisation ceased in all
thrombus within an endarterectomy zone that other- and no patient suffered a carotid thrombosis.7 How-
wise showed no evidence of underlying technical ever, 6 h of postoperative monitoring poses con-
error.6 siderable logistical and staffing problems and it would
Gaunt and Roberts subsequently demonstrated that be preferable to reduce this to the minimum in low risk
postoperative carotid thrombosis was preceded by patients. Lennard’s study also showed that patients
a 1–3 h phase of sustained, asymptomatic cerebral destined to embolise would do so within the first 3
embolisation which progressed onto clinical stroke postoperative hours. We therefore undertook a further
prospective study to see whether adoption of a 3 h
* Please address all correspondence to: A. R. Naylor, Department monitoring policy was associated with any increase inof Surgery, Clinical Sciences Building, Leicester Royal Infirmary,
U.K. the incidence of postoperative carotid thrombosis.
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Materials and Methods Following recovery from anaesthesia, the patient
was examined neurologically and transferred to the
Between 20 August 1996 and 4 December 1997, 192 High Dependency Unit for further monitoring. Any
new neurological deficit apparent upon recovery frompatients underwent either CEA (n=186) or carotid
bypass (n=6) in the Vascular Unit at Leicester Royal anaesthesia was recorded and the patient assessed by
a neurologist. Postoperative complications (i.e. fol-Infirmary for the correction of a severe internal carotid
artery (ICA) stenosis. Fifty-three patients presented lowing a normal recovery from anaesthesia and up to
30 days thereafter) were similarly documented. Ourwith a stroke (32%), 90 suffered a TIA or amaurosis
fugax (54%) while 23 were asymptomatic (14%). A protocol required us to investigate all patients awaken-
ing from anaesthesia with a new neurological deficitunilateral ICA stenosis was present in 102 (61%), bi-
lateral ICA severe stenoses in 35 (21%) while 29 (17%) by colour duplex and TCD. The decision to reoperate
was thereafter left to the discretion of the surgeon. Allhad a contralateral occlusion. A history of previous
myocardial infarction was present in 35 patients (21%), neurological deficits occurring in the postoperative
period were investigated by colour duplex, TCD, CT53 (32%) were on treatment for angina, 101 (61%) were
on treatment for hypertension while 23 (14%) were scan or re-exploration and all patients assessed by a
consultant neurologist.diabetic. Permission for this study was given by the
Leicestershire Ethics Committee.
Intraoperative transcranial Doppler monitoring
Carotid endarterectomy
Continuous TCD monitoring of blood flow velocity
Endarterectomy was performed in the same manner in the ipsilateral middle cerebral artery (MCA) was
throughout the study by a consultant vascular surgeon performed using a 2 MHz pulsed wave probe (via the
(PB, RN, NL) or higher surgical trainee under super- transtemporal window), secured with an elasticated
vision using normocarbic, normotensive general an- headband and connected to a Scimed PC842 trans-
aesthesia and systemic (5000 iu) heparinisation. All cranial system (Scimed, Bristol, U.K.). The probe was
were routinely shunted (Pruitt–Inahara), the proximal protected from dislodgement by a detachable, semi-
and distal intimal steps were tacked down with 7:0 circular metal head guard. Recording started following
prolene (Ethicon) and all arteriotomies were closed induction of anaesthesia and continued until the sur-
with a Dacron patch (Vascutek). A small number of gical drapes were removed from the patient. Data
patients (n=6) underwent a carotid bypass using re- were recorded onto digital audio tape for off-line
versed saphenous vein for the correction of very high analysis with particular emphasis on the number and
disease, gross distal kinking or the presence of an character (air versus particulate) of emboli detected
excessively thinned arterial wall following en- throughout the procedure.8,9 During the operation,
darterectomy. research staff experienced in TCD (JS, NL) were avail-
Following endarterectomy and prior to final closure able to supervise minor revisions to the probe position
of the patch, the shunt was removed, the carotid and generally advise the surgeon of unexpected phe-
vessels flushed and irrigated with heparinised saline nomena. In general, we aimed to keep mean MCA
and then reclamped. A 5 mm segment of the ar- velocity [15 cm/s throughout the procedure, pre-
teriotomy adjacent to the origin of the external carotid ferably [20 cm/s.
artery was used for angioscopic assessment5 of the
distal ICA, proximal CCA, ECA orifice and en-
darterectomy zone prior to restoration of flow using
a 5 mm diameter flexible hysteroscope (Olympus 1070– Postoperative TCD monitoring
48). The policy of the unit was to remove any fragments
of thrombus and repair any intimal flap >3 mm. Where Twenty-six of the 192 patients in the study period
were not monitored in the early postoperative periodnecessary, an estimate of luminal sizing of an ab-
normality was based on comparison with the 2 mm because of an inaccessible window, technical problems
or because a simultaneous CEA was being performeddiameter head of the forceps that could be passed
down the instrument channel of the hysteroscope. If which required the presence of the monitoring staff.
Accordingly, ipsilateral MCAV data were recorded forany abnormality required correction, the en-
darterectomy zone was routinely re-examined to con- 10 min every 30 min for 3 h in 166 patients following
restoration of flow. Any patient who had [25 embolifirm that there was no residual abnormality.
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Fig. 1. Effect of dextran therapy in nine patients with either sustained embolisation or emboli which distorted the MCA waveform. The
three patients who required an increase in their dose of dextran are highlighted by the bold lines. The remainder all stabilised on a base
infusion rate of 20 ml/h.
detected during any 10 min period of monitoring or effect of dextran on the ensuing embolus count. In the
majority of patients the embolus count fell rapdilyany patient whose emboli caused distortion of the
MCA waveform (suggesting a large embolus) was but in three patients, the rate of infusion had to be
progressively increased either because the emboluscommenced on an incremental intravenous infusion
of dextran 40, starting at a rate of 20 ml/h. If the rate count rate did not diminish (n=1) or because the
embolus rate actually increased (n=2). However, allof embolisation did not diminish, the infusion was
gradually increased by 5 ml/h every 10 min to a patients had ceased embolising whilst on the Dextran
therapy. One of the nine required monitoring for 8 hmaximum of 40 ml/h. Patients receiving dextran were
monitored by TCD for 6 h after restoration of flow. overall while a further four were monitored for a total
of 4 h. Thus overall, 97% of the 166 patients wereOnce the dextran infusion rate was stabilised, it was
then continued at that dose for a further 12 h. monitored for only 3 h, 2% for 4 h and 1% for >4 h.
All patients were discharged home on aspirin ther-
apy (75 mg daily), on the fifth postoperative day, and
all were reviewed 6 weeks later in the Vascular Clinic.
Operative morbidity and mortality
Results a) Intraoperative morbidity. One patient (0.6%) recovered
from anaesthesia with a new neurological deficit. He
Numbers and timing of emboli had a contralateral occlusion and underwent a vein
bypass for disease extending up to the skull base.
Seventy-six patients (46%) had no emboli detected During carotid clamping there was no MCA flow
during the first 3 h of postoperative monitoring, while on TCD indicating inadequate collateralisation. Good
79 (48%) had 1–25 emboli, seven (4%) had 26–50 emboli MCA flow signals were obtained following restoration
and four (2%) had [51 emboli detected. Of the 90 of flow but after 2 min there were increasing embolic
patients found to have one or more emboli, 43 (48%) signals and MCA velocity began to fall rapidly despite
had their first embolus detected within the first post- having commenced an on-table dextran infusion.
operative hour, 43 (48%) started to embolise in the Angiography revealed thrombus within the mid-por-
second hour while only four (4%) had their first em- tion of the graft. The shunt was reinserted, the throm-
bolus detected in the third hour. Thus, overall 95% of bus removed and the graftotomy closed primarily after
those who were destined to embolise did so within no obvious technical error was identified. Five minutes
the first 2 postoperative hours. after secondary restoration of flow, profuse em-
bolisation recurred, MCA flow again diminished to-
wards that observed during carotid clamping and
the bypass graft was again reopened after anotherDextran 40 therapy
angiogram indicated thrombus at the distal ana-
stomosis. The graft was reopened, the thrombus re-Nine patients (5%) were commenced on postoperative
intravenous dextran 40 therapy. Fig. 1 illustrates the moved and a vein patch inserted across the
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anastomosis despite the absence of any obvious tech- neck haematomas requiring re-exploration and one
patient died of multiorgan failure which was spe-nical error. Thereafter MCA flow was maintained and
no further episode of on-table thrombosis occurred. cifically attributed by the nephrologists to our use of
dextran.The patient subsequently recovered from anaesthesia
with aphasia (but no motor deficit) which had sig- Faced with this, we implemented a revised protocol
in October 1995 whereupon dextran was only givennificantly improved for him to be classed as a non-
disabling stroke by day 30. to patients with sustained embolisation ([25 emboli
in any 10 min period during a 6 h phase of TCD
(b) Postoperative morbidity and mortality. One patient monitoring) and who were therefore considered high
who underwent an emergency CEA for crescendo TIAs risk for thrombosis. In this pilot study, 5% of patients
suffered a fatal myocardial infarction on day 3 despite required dextran therapy and embolisation ceased in
having undergone full preoperative cardiological all. More importantly, no patient suffered a carotid
assessment to give an overall 30-day operative mor- thrombosis in that series. However, implementing a
tality rate of 0.6%. One further patient suffered a routine policy of 6 h of TCD monitoring after CEA
disabling stroke on day 22 following a CT scan proven poses important logistical problems, not least man-
intracerebral haemorrhage. Neither of these two power. We therefore undertook a second study which
patients had received dextran therapy in the post- took advantage of an observation that was made dur-
operative period. One further patient received dextran ing Lennard’s original work. It was noted that >95%
in the immediate postoperative period which con- of patients who were destined to embolise would do
trolled his embolisation. However, on the fifth post- so within the first 3 postoperative hours.7 We therefore
operative day he developed a monoplegia of his arm. hypothesised that it may be feasible to reduce the
Duplex scanning revealed a diffuse irregularity of the postoperative monitoring to 3 h without significantly
distal endarterectomy/ICA and TCD revealed profuse increasing the risk of postoperative thrombosis.
cerebral embolisation. Dextran was recommenced at The findings of this latest study appears to support
50 ml/h and this rapidly controlled the embolisation our hypothesis. The vast majority of patients (96%)
and he went on to make a full neurological recovery who are destined to have any emboli will start within
(grade 0 at 30 days). 2 h but very few (5%) will require intervention with
Thus overall the death and disabling stroke rate was dextran. No patient in this series suffered a stroke due
1.2% while the death/any stroke rate was 2.4%. to a carotid thrombosis within 30 days of surgery.
These findings therefore suggest that 90–95% of low
risk patients require only 2–3 h of monitoring while
Discussion 5–10% higher risk patients might require longer
periods of assessment. Our evidence suggests however
At the beginning of our research programme in 1992, that only 1% will require prolonged monitoring
we hypothesised that the implementation of a quality beyond 4 h.
control programme would reduce the rate of operation This study has also shown that no single dose
related stroke through the early detection and cor- of dextran will guarantee control of postoperative
rection of inadvertent technical error.4 Our subsequent embolisation. In this series, three of the nine patients
experience with the pilot study and a follow-up audit (33%) required progressive increments in their Dextran
study in 1995 confirmed that while the quality control therapy in order to control the embolisation and this
programme was associated with a significant fall in is in accordance with our experience in the earlier pilot
the rate of intraoperative stroke from 4% prior to 1992 study.7 This therefore suggests that implementation of
to 0.3% by 1995,4,5 it had little impact on the rate a routine policy of postoperative dextran therapy will
of postoperative thrombotic stroke which remained probably reduce the overall risk of postoperative ca-
stubbornly at 2.7%. however, Gaunt1,2 and Roberts3 rotid thrombosis but it will almost certainly not abolish
subsequently demonstrated that postoperative carotid it. Moreover, this study is the first to demonstrate that
thrombosis is preceded by a phase of asymptomatic but certain patients may start to re-embolise after some
sustained micro-embolisation that could be detected by days have passed. This particular patient was high
TCD. At the time we had no facility for extending the risk for re-exploration which might otherwise have
TCD monitoring into the early postoperative period dislodged the luminal thrombus. His initially high rate
and we therefore decided to administer dextran (an of embolisation on day 5 settled rapidly with the high
antiplatelet agent) to all patients postoperatively. Un- dose dextran and a check duplex scan at 30 days
fortunately, while this policy abolished carotid throm- showed no evidence of any residual stenosis or
thrombus.bosis it was associated with a rise in the number of
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